Health
Johnson & Johnson expects no new Covid vaccine revenue, after shots drive earnings beat
The Janssen Johnson & Johnson COVID-19 vaccine. Allen J. Schaben | Los Angeles Times | Getty Images International Covid vaccine sales helped spark Johnson & Johnson‘s revenue and earnings beat on Tuesday, but the company said it expects no sales from the shot moving forward. “Regarding our Covid-19 vaccine, we do not anticipate material sales […]
Read More
J&J’s 2025 drug sales forecast should not be tripping up investors. There’s so much else like
Johnson & Johnson (JNJ) before-the-bell Tuesday reported a strong first quarter, with sales up more than 5.5% and earnings eking out an annual increase. Shares of the Dow component and Club holding should not be losing 2.5% on these kinds of results. J & J’s first-quarter sales of $24.75 billion exceeded the Refinitv consensus estimate […]
Read More
Wall Street upgrades Emerson and Danaher, while Apple expands in India. Here are the Club stocks making headlines Tuesday
Wall Street on Tuesday upgraded two underperforming Club stocks — Emerson Electric (EMR) and Danaher (DHR) — to the equivalent of buy ratings. Meanwhile, longtime core holding Apple (AAPL) took another step forward in a key global smartphone market. EMR YTD mountain Emerson Electric’s year-to-date stock performance. The news: Wolfe Research on Tuesday upgraded Emerson […]
Read More
Anti-abortion group asks Supreme Court to keep mifepristone restrictions
Anti-abortion demonstrators celebrate outside the United States Supreme Court as the court rules in the Dobbs v Women’s Health Organization abortion case, overturning the landmark Roe v Wade abortion decision in Washington, U.S., June 24, 2022. Evelyn Hockstein | Reuters An anti-abortion group on Tuesday asked the Supreme Court to keep restrictions on the abortion […]
Read More
FDA authorizes additional omicron Covid booster for seniors and people with weak immune systems
Sylvester Fisher gets a influenza vaccine from pharmacist Patricia Pernal during an event hosted by the Chicago Department of Public Health at the Southwest Senior Center on September 09, 2022 in Chicago, Illinois. The vaccines were being offered along with pneumonia vaccines and the recently authorized COVID-19 booster vaccine, which protects against the original SARS-CoV-2 […]
Read More
Club meeting recap: Jim Cramer says Johnson & Johnson’s post-earnings sell-off is wrong and a chance to buy
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. Dow drops with earnings in focus J & J decline misguided Starbucks undervalued? 1. Dow drops with earnings in focus Stocks fell Tuesday as Dow stocks Goldman Sachs (GS) and […]
Read More
Johnson & Johnson beats on earnings and revenue, raises full-year guidance
Artur Widak | NurPhoto | Getty Images Johnson & Johnson reported adjusted earnings and revenue that topped Wall Street’s expectations on Tuesday, and lifted its full-year forecast. J&J, whose financial results are considered a bellwether for many health companies, said its first-quarter sales grew 5.6% over the same quarter last year. The consumer staples giant reported […]
Read More
Moderna shares fall despite promising data from cancer vaccine trial
Sopa Images | Lightrocket | Getty Images Shares of Moderna fell Monday as Wall Street chewed over new trial results on the personalized cancer vaccine it is developing with Merck. Merck’s shares were relatively flat. The experimental mRNA vaccine, when combined with Merck’s blockbuster drug Keytruda, cut the risk of recurrence of skin cancer melanoma […]
Read More
Abortion providers rush to make backup plans as Supreme Court decides whether to keep limits on mifepristone
U.S. abortion pill providers are scrambling to make backup plans as the Supreme Court decides whether to keep restrictions on the key drug mifepristone. Some in-person clinics in New York, California and Kansas will offer mifepristone for now, but are preparing to provide an alternative abortion pill if a subsequent decision essentially bans the drug. […]
Read More
Supreme Court lifts abortion pill restrictions for now
U.S. Supreme Court Justice Samuel Alito on Friday temporarily blocked lower court rulings that imposed tighter restrictions on the abortion pill mifepristone. U.S. Judge Matthew Kacsmaryk of the U.S. Northern District of Texas suspended the Food and Drug Administration’s approval of mifepristone last week. The U.S. 5th Circuit Court of Appeals blocked that part of […]
Read More